Annual CFO
-$4.89 M
+$1.75 M+26.31%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual cash flow from operations is -$4.89 million, with the most recent change of +$1.75 million (+26.31%) on September 30, 2024.
- During the last 3 years, EDSA annual CFO has risen by +$8.77 million (+64.21%).
- EDSA annual CFO is now -12871.35% below its all-time high of -$37.70 thousand, reached on April 30, 2009.
Performance
EDSA Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$967.00 K
-$110.50 K-12.90%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly cash flow from operations is -$967.00 thousand, with the most recent change of -$110.50 thousand (-12.90%) on September 30, 2024.
- Over the past year, EDSA quarterly CFO has increased by +$693.20 thousand (+41.75%).
- EDSA quarterly CFO is now -1110.26% below its all-time high of -$79.90 thousand, reached on November 30, 2010.
Performance
EDSA Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$4.89 M
+$501.00 K+9.29%
September 30, 2024
Summary
- As of February 12, 2025, EDSA TTM cash flow from operations is -$4.89 million, with the most recent change of +$501.00 thousand (+9.29%) on September 30, 2024.
- Over the past year, EDSA TTM CFO has increased by +$1.45 million (+22.87%).
- EDSA TTM CFO is now -6020.40% below its all-time high of -$79.90 thousand, reached on November 30, 2010.
Performance
EDSA TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
EDSA Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.3% | +41.8% | +22.9% |
| 3 y3 years | +64.2% | +46.4% | +54.7% |
| 5 y5 years | -0.9% | +46.4% | +54.7% |
EDSA Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.2% | -132.1% | +82.8% | at high | +64.7% |
| 5 y | 5-year | -0.9% | +64.2% | -172.2% | +86.5% | -149.5% | +67.4% |
| alltime | all time | <-9999.0% | +64.2% | -1110.3% | +86.5% | -6020.4% | +67.4% |
Edesa Biotech Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$4.89 M(-26.3%) | -$967.00 K(+12.9%) | -$4.89 M(-9.3%) |
| Jun 2024 | - | -$856.50 K(-48.4%) | -$5.39 M(-15.0%) |
| Mar 2024 | - | -$1.66 M(+18.0%) | -$6.34 M(+1.4%) |
| Dec 2023 | - | -$1.41 M(-4.2%) | -$6.25 M(-5.8%) |
| Sep 2023 | -$6.64 M(-46.0%) | -$1.47 M(-18.7%) | -$6.64 M(-38.5%) |
| Jun 2023 | - | -$1.81 M(+14.8%) | -$10.80 M(-10.2%) |
| Mar 2023 | - | -$1.57 M(-12.2%) | -$12.02 M(+10.6%) |
| Dec 2022 | - | -$1.79 M(-68.2%) | -$10.86 M(-11.5%) |
| Sep 2022 | -$12.28 M(-10.1%) | -$5.63 M(+85.9%) | -$12.28 M(+75.3%) |
| Jun 2022 | - | -$3.03 M(+626.4%) | -$7.01 M(-1.3%) |
| Mar 2022 | - | -$416.70 K(-87.0%) | -$7.10 M(-48.8%) |
| Dec 2021 | - | -$3.21 M(+802.8%) | -$13.86 M(+1.4%) |
| Sep 2021 | -$13.66 M(+174.0%) | -$355.30 K(-88.6%) | -$13.66 M(-8.8%) |
| Jun 2021 | - | -$3.12 M(-56.5%) | -$14.98 M(+13.4%) |
| Mar 2021 | - | -$7.18 M(+138.5%) | -$13.22 M(+83.4%) |
| Dec 2020 | - | -$3.01 M(+80.0%) | -$7.21 M(+44.5%) |
| Sep 2020 | -$4.99 M(+2.9%) | -$1.67 M(+23.6%) | -$4.99 M(+50.5%) |
| Jun 2020 | - | -$1.35 M(+15.6%) | -$3.31 M(+69.0%) |
| Mar 2020 | - | -$1.17 M(+48.2%) | -$1.96 M(-2.7%) |
| Dec 2019 | - | -$789.70 K(-35.6%) | -$2.02 M(-56.4%) |
| Sep 2019 | -$4.85 M(+5.0%) | - | - |
| Mar 2019 | - | -$1.23 M(-6.4%) | -$4.62 M(-3.4%) |
| Dec 2018 | - | -$1.31 M(+34.8%) | -$4.78 M(+3.6%) |
| Sep 2018 | -$4.62 M(-1.8%) | -$971.20 K(-12.6%) | -$4.62 M(-3.1%) |
| Jun 2018 | - | -$1.11 M(-20.0%) | -$4.76 M(+3.7%) |
| Mar 2018 | - | -$1.39 M(+21.3%) | -$4.59 M(+2.5%) |
| Dec 2017 | - | -$1.14 M(+2.5%) | -$4.48 M(-4.7%) |
| Sep 2017 | -$4.70 M | -$1.12 M(+18.7%) | -$4.70 M(-1.6%) |
| Jun 2017 | - | -$941.30 K(-26.2%) | -$4.77 M(-2.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2017 | - | -$1.28 M(-6.5%) | -$4.90 M(+4.3%) |
| Dec 2016 | - | -$1.36 M(+14.5%) | -$4.70 M(+4.2%) |
| Sep 2016 | -$4.51 M(+2.1%) | -$1.19 M(+11.7%) | -$4.51 M(+6.5%) |
| Jun 2016 | - | -$1.07 M(-0.6%) | -$4.23 M(+3.7%) |
| Mar 2016 | - | -$1.07 M(-8.6%) | -$4.08 M(-5.2%) |
| Dec 2015 | - | -$1.17 M(+28.3%) | -$4.30 M(-2.5%) |
| Sep 2015 | -$4.41 M(+1387.2%) | -$915.10 K(-0.1%) | -$4.41 M(+2.3%) |
| Jun 2015 | - | -$915.80 K(-29.3%) | -$4.31 M(-2.7%) |
| Mar 2015 | - | -$1.30 M(+0.8%) | -$4.43 M(+1.5%) |
| Dec 2014 | - | -$1.29 M(+57.4%) | -$4.37 M(+2.3%) |
| Sep 2014 | -$296.70 K(-93.0%) | - | - |
| Aug 2014 | -$4.27 M(+52.6%) | -$816.60 K(-21.1%) | -$4.27 M(+6.4%) |
| May 2014 | - | -$1.03 M(-15.8%) | -$4.01 M(+8.3%) |
| Feb 2014 | - | -$1.23 M(+3.6%) | -$3.70 M(+13.5%) |
| Nov 2013 | - | -$1.19 M(+112.4%) | -$3.26 M(+16.6%) |
| Aug 2013 | -$2.80 M(-29.2%) | -$558.80 K(-23.1%) | -$2.80 M(-11.6%) |
| May 2013 | - | -$726.20 K(-7.9%) | -$3.16 M(-8.1%) |
| Feb 2013 | - | -$788.80 K(+9.3%) | -$3.44 M(-9.0%) |
| Nov 2012 | - | -$722.00 K(-21.9%) | -$3.78 M(-4.3%) |
| Aug 2012 | -$3.95 M(+50.8%) | -$924.50 K(-8.0%) | -$3.95 M(+0.4%) |
| May 2012 | - | -$1.00 M(-10.9%) | -$3.93 M(+0.4%) |
| Feb 2012 | - | -$1.13 M(+26.6%) | -$3.92 M(+14.3%) |
| Nov 2011 | - | -$890.90 K(-1.9%) | -$3.43 M(+31.0%) |
| Aug 2011 | -$2.62 M(+257.5%) | -$908.30 K(-8.3%) | -$2.62 M(+53.1%) |
| May 2011 | - | -$990.60 K(+55.0%) | -$1.71 M(+137.8%) |
| Feb 2011 | - | -$638.90 K(+699.6%) | -$718.80 K(+799.6%) |
| Nov 2010 | - | -$79.90 K | -$79.90 K |
| Aug 2010 | -$732.20 K(+1842.2%) | - | - |
| Apr 2009 | -$37.70 K | - | - |
FAQ
- What is Edesa Biotech annual cash flow from operations?
- What is the all time high annual CFO for Edesa Biotech?
- What is Edesa Biotech annual CFO year-on-year change?
- What is Edesa Biotech quarterly cash flow from operations?
- What is the all time high quarterly CFO for Edesa Biotech?
- What is Edesa Biotech quarterly CFO year-on-year change?
- What is Edesa Biotech TTM cash flow from operations?
- What is the all time high TTM CFO for Edesa Biotech?
- What is Edesa Biotech TTM CFO year-on-year change?
What is Edesa Biotech annual cash flow from operations?
The current annual CFO of EDSA is -$4.89 M
What is the all time high annual CFO for Edesa Biotech?
Edesa Biotech all-time high annual cash flow from operations is -$37.70 K
What is Edesa Biotech annual CFO year-on-year change?
Over the past year, EDSA annual cash flow from operations has changed by +$1.75 M (+26.31%)
What is Edesa Biotech quarterly cash flow from operations?
The current quarterly CFO of EDSA is -$967.00 K
What is the all time high quarterly CFO for Edesa Biotech?
Edesa Biotech all-time high quarterly cash flow from operations is -$79.90 K
What is Edesa Biotech quarterly CFO year-on-year change?
Over the past year, EDSA quarterly cash flow from operations has changed by +$693.20 K (+41.75%)
What is Edesa Biotech TTM cash flow from operations?
The current TTM CFO of EDSA is -$4.89 M
What is the all time high TTM CFO for Edesa Biotech?
Edesa Biotech all-time high TTM cash flow from operations is -$79.90 K
What is Edesa Biotech TTM CFO year-on-year change?
Over the past year, EDSA TTM cash flow from operations has changed by +$1.45 M (+22.87%)